International Journal of Biological Sciences,
Journal Year:
2024,
Volume and Issue:
20(11), P. 4438 - 4457
Published: Jan. 1, 2024
Metabolic
dysfunction-associated
steatotic
liver
disease
(MASLD)
is
a
chronic,
progressive
that
encompasses
spectrum
of
steatosis,
steatohepatitis
(or
MASH),
and
fibrosis.
Evidence
suggests
dietary
restriction
(DR)
sleeve
gastrectomy
(SG)
can
lead
to
remission
hepatic
steatosis
inflammation
through
weight
loss,
but
it
unclear
whether
these
procedures
induce
distinct
metabolic
or
immunological
changes
in
MASLD
livers.
This
study
aims
elucidate
the
intricate
following
DR,
SG
sham
surgery
rats
fed
high-fat
diet
as
model
obesity-related
MASLD,
comparison
clinical
cohort
patients
undergoing
SG.
Single-cell
single-nuclei
transcriptome
analysis,
spatial
metabolomics,
immunohistochemistry
revealed
landscape,
while
circulating
biomarkers
were
measured
serum
samples.
Artificial
intelligence
(AI)-assisted
image
analysis
characterized
distribution
hepatocytes,
myeloid
cells
lymphocytes.
In
experimental
rats,
improved
body
mass
index,
injury
triglyceride
levels.
Both
DR
attenuated
fibrosis
rats.
Metabolism-related
genes
(
Japanese Journal of Clinical Oncology,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 12, 2025
Abstract
The
concept
and
definition
of
combined
hepatocellular-cholangiocarcinoma
(cHCC-CCA),
an
extremely
rare
condition
accounting
for
only
1%
all
primary
liver
cancers,
has
shifted
in
recent
years.
latest
World
Health
Organization
Classification
(fifth
edition)
includes
two
types
cHCC-CCAs,
(i)
the
classical
type
described
previous
edition,
which
contains
a
mixture
distinctly
differentiated
components
both
hepatocellular
carcinoma
(HCC)
intrahepatic
cholangiocarcinoma
(ICC)
(ii)
intermediate
cell
wherein
cells
comprising
tumor
express
cholangiocellular
features.
However,
pathogenesis
cHCC-CCA,
including
its
origins,
remains
controversial
even
among
experts.
Treatment
strategies
cHCC-CCA
clinical
practice
have
been
determined
based
on
imaging
findings,
markers,
pathologically
predominant
either
HCC
or
ICC,
suggesting
that
yet
to
be
established
as
independent
disease
entity.
As
with
treatment
strategy
HCC-CCA
involves
initially
considering
resectability.
Although
systemic
therapy
considered
patients
unsuitable
local
treatment,
no
prospective
trials
evaluated
efficacy
safety
could
explain
lack
standard
care.
In
years,
however,
studies
demonstrated
immune
checkpoint
inhibitors
therapeutic
results
having
reported
cHCC-CCA.
Hence,
further
accumulation
cases
is
expected
facilitate
establishment
consensus
near
future.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
14
Published: Feb. 13, 2025
Objective
To
analyze
the
research
hotspots
and
potential
of
Artificial
Intelligence
(AI)
in
cholangiocarcinoma
(CCA)
through
visualization.
Methods
A
comprehensive
search
publications
on
application
AI
CCA
from
January
1,
2014,
to
December
31,
2023,
within
Web
Science
Core
Collection,
was
conducted,
citation
information
extracted.
CiteSpace
6.2.R6
used
for
visualization
analysis
information.
Results
total
736
were
included
this
study.
Early
primarily
focused
traditional
treatment
methods
care
strategies
CCA,
but
since
2019,
there
has
been
a
significant
shift
towards
development
optimization
algorithms
their
early
cancer
diagnosis
decision-making.
China
emerged
as
country
with
highest
volume
publications,
while
Khon
Kaen
University
Thailand
academic
institution
number
publications.
core
group
authors
involved
dense
network
international
collaboration
identified.
HEPATOLOGY
found
be
most
influential
journal
field.
The
disciplinary
pattern
domain
exhibits
characteristic
multiple
disciplines
intersecting
integrating.
Conclusion
current
revolve
around
three
directions:
classification
preoperative
assessment
metastasis
risk
prediction
postoperative
recurrence
CCA.
complementarity
interdependence
among
different
applications
will
facilitate
future
Advanced Science,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 17, 2025
Abstract
Hepatocellular
carcinoma
(HCC)
is
a
major
cause
of
cancer‐related
mortality,
while
the
hepatocyte
mechanisms
driving
oncogenesis
remains
poorly
understood.
In
this
study,
single‐nucleus
RNA
sequencing
samples
from
22
HCC
patients
revealed
10
distinct
subtypes,
including
beneficial
Hep0,
predominantly
malignant
Hep2,
and
immunosuppressive
Hep9.
These
subtypes
were
strongly
associated
with
patient
prognosis,
confirmed
in
TCGA‐LIHC
Fudan
cohorts
through
composition
deconvolution.
A
quantile‐based
scoring
method
developed
to
integrate
data
29
public
datasets,
creating
Quantile
Distribution
Model
(QDM)
excellent
diagnostic
accuracy
(Area
Under
Curve,
AUC
=
0.968‐0.982).
QDM
was
employed
screen
potential
biomarkers,
revealing
that
PDE7B
functions
as
key
gene
whose
suppression
promotes
progression.
Guided
by
genes
specific
Hep0/2/9
categorized
into
metabolic,
inflammatory,
matrix
classes,
which
are
distinguishable
mutation
frequencies,
survival
times,
enriched
pathways,
immune
infiltration.
Meanwhile,
sensitive
drugs
three
classes
identified,
namely
ouabain,
teniposide,
TG‐101348.
This
study
presents
largest
single‐cell
dataset
date,
offering
transformative
insights
hepatocarcinogenesis
comprehensive
framework
for
advancing
diagnostics,
prognostics,
personalized
treatment
strategies.
AJP Gastrointestinal and Liver Physiology,
Journal Year:
2024,
Volume and Issue:
327(1), P. G1 - G15
Published: April 23, 2024
BiliQML
is
the
first
comprehensive
machine-learning
platform
for
biliary
form
analysis
in
whole
slide
histopathological
images.
This
provides
clinical
and
basic
science
researchers
with
a
novel
tool
improved
quantification
characterization
of
tract
disorders.
World Journal of Hepatology,
Journal Year:
2024,
Volume and Issue:
16(5), P. 766 - 775
Published: May 22, 2024
Combined
hepatocellular-cholangiocarcinoma
(cHCC-CCA)
is
a
rare
primary
liver
cancer
associated
with
an
appalling
prognosis.
The
diagnosis
and
management
of
this
entity
have
been
challenging
to
physicians,
radiologists,
surgeons,
pathologists,
oncologists
alike.
diagnostic
prognostic
value
biomarkers
such
as
the
immunohistochemical
expression
nestin,
progenitor
cell
marker,
explored
recently.
With
better
understanding
biology
clinical
course
cHCC-CCA,
newer
treatment
modalities
like
immune
checkpoint
inhibitors
are
being
tried
improve
survival
patients
disease.
In
review,
we
give
account
recent
developments
in
pathology,
approach,
cHCC-CCA.
Nano Letters,
Journal Year:
2024,
Volume and Issue:
24(28), P. 8784 - 8792
Published: July 8, 2024
The
detection
of
hepatitis
B
surface
antigen
(HBsAg)
is
critical
in
diagnosing
virus
(HBV)
infection.
However,
existing
clinical
technologies
inevitably
cause
certain
inaccuracies,
leading
to
delayed
or
unwarranted
treatment.
Here,
we
introduce
a
label-free
plasmonic
biosensing
method
based
on
the
thickness-sensitive
coupling,
combined
with
supervised
deep
learning
(DL)
using
neural
networks.
strategy
utilizing
networks
process
output
data
can
reduce
limit
(LOD)
sensor
and
significantly
improve
accuracy
(from
93.1%-97.4%
99%-99.6%).
Compared
widely
used
emerging
technologies,
our
platform
achieves
accurate
decisions
higher
sensitivity
short
assay
time
(∼30
min).
integration
DL
models
considerably
simplifies
readout
procedure,
resulting
substantial
decrease
processing
time.
Our
findings
offer
promising
avenue
for
developing
high-precision
molecular
tools
point-of-care
(POC)
applications.
Current Opinion in Electrochemistry,
Journal Year:
2024,
Volume and Issue:
46, P. 101526 - 101526
Published: April 26, 2024
Despite
the
noteworthy
progress
in
Single
Entity
Electrochemistry
(SEE)
last
decade,
field
still
must
undergo
further
advancements
to
attain
requisite
maturity
for
facilitating
and
propelling
machine
learning
(ML)-based
discoveries.
This
mini-review
presents
an
analysis
of
required
developments
domain,
using
success
AlphaFold
biology
as
a
benchmark
future
progress.
The
first
essential
requirement
is
creation
support
high-quality,
centralized,
open-access
databases
on
electrochemical
properties
single
entities.
should
be
facilitated
through
automation
standardization
experiments,
promoting
high-throughput
output
comparison
between
datasets.
Finally,
new
type
interdisciplinary
specialist,
trained
pinpoint
critical
issues
SEE
implement
solutions
from
applied
informatics,
vital
ML
approaches
flourish
field.